$ATTO 3 SEC Filings

Filed On	Filing
05 Aug 2026	Form 3: Alamar HoldCo, Llc, 10% owner Holds 3,229,278 shares of Common Stock
05 Aug 2026	Form 3: Walsh Colin, Director
04 Aug 2026	Form 3: Deep Track Biotechnology Master Fund, Ltd., 10% owner and 2 others
04 Aug 2026	Form 3: Redmile Group, Llc, 10% owner and 2 others
04 Aug 2026	Form 3: Vida Ventures Gp III, L.l.c., 10% owner and 2 others
04 Aug 2026	Form 3: venBio Global Strategic Fund IV, L.p., 10% owner
04 Aug 2026	Form 3: You Angie, Director Holds 52,852 shares of Common Stock
04 Aug 2026	Form 3: Veiby Petter, Chief Scientific Officer Holds 104,951 shares of Common Stock
04 Aug 2026	Form 3: Royston Aaron, Director No securities owned
04 Aug 2026	Form 3: Attovia Therapeutics, Inc., Chief Financial Officer
04 Aug 2026	Form 3: Odrowaz Zaneta, Chief Business Officer Holds 103,269 shares of Common Stock
04 Aug 2026	Form 3: Attovia Therapeutics, Inc., Director Holds 87,843 shares of Common Stock
04 Aug 2026	Form 3: Gold Mitchell, Director
04 Aug 2026	Form 3: Topper James N, Director No securities owned
04 Aug 2026	Form 3: Chen Hubert, Chief Medical Officer Holds 2,960 shares of Common Stock
04 Aug 2026	Form 3: Smither John W, Director
04 Aug 2026	Form 3: Goldman Sachs Group Inc, 10% owner and 7 others
04 Aug 2026	Form 3: Frazier Life Sciences XI, L.p., 10% owner and 2 others Holds 75,349 shares of Common Stock
04 Aug 2026	Form 3: Sanofi, 10% owner

Comments